Ausgabe 3/2022
Inhalt (18 Artikel)
Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis
Matthew G. Davey, Eoin F. Cleere, John P. O’Donnell, Sara Gaisor, Aoife J. Lowery, Michael J. Kerin
Standardization of the tumor-stroma ratio scoring method for breast cancer research
Sophie C. Hagenaars, Kiki M. H. Vangangelt, Gabi W. Van Pelt, Zsófia Karancsi, Rob A. E. M. Tollenaar, Andrew R. Green, Emad A. Rakha, Janina Kulka, Wilma E. Mesker
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)
Charles E. Geyer Jr., Hanna Bandos, Priya Rastogi, Samuel A. Jacobs, André Robidoux, Louis Fehrenbacher, Patrick J. Ward, Jonathan Polikoff, Adam M. Brufsky, Louise Provencher, Alexander H. G. Paterson, John T. Hamm, Robert L. Carolla, Luis Baez-Diaz, Thomas B. Julian, Sandra M. Swain, Eleftherios P. Mamounas, Norman Wolmark
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)
Charles E. Geyer Jr., Hanna Bandos, Priya Rastogi, Samuel A. Jacobs, André Robidoux, Louis Fehrenbacher, Patrick J. Ward, Jonathan Polikoff, Adam M. Brufsky, Louise Provencher, Alexander H. G. Paterson, John T. Hamm, Robert L. Carolla, Luis Baez-Diaz, Thomas B. Julian, Sandra M. Swain, Eleftherios P. Mamounas, Norman Wolmark
Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer
Annelieke A. Lemij, Nienke A. de Glas, Marloes G. M. Derks, Esther Bastiaannet, Jos W. S. Merkus, Titia E. Lans, Carmen C. van der Pol, Thijs van Dalen, Annelie J. E. Vulink, Leander van Gerven, Onno R. Guicherit, Eugenie M. H. Linthorst-Niers, Frederiek van den Bos, Judith R. Kroep, Gerrit Jan Liefers, Johanneke E. A. Portielje
Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast)
Elizabeth O’Donnell, Yael Shapiro, Amy Comander, Steven Isakoff, Beverly Moy, Laura Spring, Seth Wander, Irene Kuter, Jennifer Shin, Michelle Specht, Chryssanthi Kournioti, Bonnie Hu, Carol Sullivan, Loren Winters, Nora Horick, Jeffrey Peppercorn
False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy
Jana de Boniface, Jan Frisell, Thorsten Kühn, Ingrid Wiklander-Bråkenhielm, Karin Dembrower, Per Nyman, Athanasios Zouzos, Bernd Gerber, Toralf Reimer, Steffi Hartmann
Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years
Lisi M. Dredze, Michael Friger, Samuel Ariad, Michael Koretz, Bertha Delgado, Ruthy Shaco-Levy, Margarita Tokar, Michael Bayme, Ravit Agassi, Maia Rosenthal, Victor Dyomin, Olga Belochitski, Shai Libson, Tamar Mizrahi, David B. Geffen
Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases
Akshjot Puri, Charisma Mylavarapu, Jiaqiong Xu, Tejal A. Patel, Bin S.Teh, Ivo Tremont-Lukats, Jenny C. Chang, Polly Niravath
Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer
Temidayo A. Fadelu, Parsa Erfani, Joarly Lormil, Ruth Damuse, Viergela Pierre, Sarah Slater, Scott A. Triedman, Lawrence N. Shulman, Timothy R. Rebbeck
RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis
Dooreh Kim, Soong June Bae, Sung Gwe Ahn, Joon Jeong, Seho Park, Woo-Chan Park, Goeun Park, Sujee Lee, Chang Ik Yoon
Prognostic significance of abdominal obesity and its post-diagnosis change in a Chinese breast cancer cohort
Gary K. K. Chung, Winnie Yeo, Ashley Cheng, Carol Kwok, Yuanyuan Lei, Ka Li Cheung, Roselle Lee, Suzanne C. Ho
Breast-conserving surgery with whole breast radiation therapy has a subsequent lower mood disorder incidence rate than total mastectomy in early-stage breast cancer patients: a nationwide population-based longitudinal study
Yen-Hsiang Liao, Jung-Nien Lai, Ren-Jun Hsu, Tzu-Hwei Wang, Chen-Ta Wu, Sheng-Yao Huang, Lu-Ting Chiu, Wen-Lin Hsu, Dai-Wei Liu
Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer
Marilyn L. Kwan, Richard K. Cheng, Carlos Iribarren, Hanjie Shen, Cecile A. Laurent, Janise M. Roh, Dawn L. Hershman, Lawrence H. Kushi, Heather Greenlee, Jamal S. Rana
Association between weight change and breast cancer prognosis
Yi-Xin Zhang, Zhuo-Zhi Liang, Yun-qian Li, Ying Lin, Qiang Liu, Xiao-Ming Xie, Lu-Ying Tang, Ze-Fang Ren
Work ability 8 years after breast cancer: exploring the role of social support in a nation-wide survey
K. Vandraas, R. S. Falk, S. K. H. Bøhn, C. Kiserud, H. C. Lie, S. K. Smedsland, M. Ewertz, S. Dahl, M. Brekke, K. V. Reinertsen
Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010–2017
Hanxi Zhang, Jamie C. Barner, Leticia R. Moczygemba, Karen L. Rascati, Chanhyun Park, Dhatri Kodali
Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity
Hsiao-Ching Huang, Mary H. Smart, Ashwini Zolekar, Huiwen Deng, Colin C. Hubbard, Kent F. Hoskins, Naomi Y. Ko, Jenny S. Guadamuz, Gregory S. Calip